Prognostic Impact of Acute Kidney Injury Following Tricuspid Transcatheter Edge-to-Edge Repair

Tricuspid failure (TF) mostly affects the elderly and, because of this, is associated with comorbidities that increase surgical risk. 

La insuficiencia renal post tratamiento borde a borde tricuspídeo impacta en el pronóstico

Tricuspid edge to edge repair (TEER) has surged as a valid alternative for the mitral valve in high-risk patients and, at present, is increasingly being used for tricuspids. 

One of the complications following TEER is acute kidney injury (AKI), which in case of edge-to-edge repair happens in 1 every 6 patients and has prognostic impact. 

This complication has not yet been well assessed for right atrioventricular valves undergoing TEER. 

This is a retrospective registry of two centers in Germany including 268 patients with TF undergoing TEER with MitraClip, TriClip or Pascal. 42 of these patients presented AKI (15.7%). 

Primary end point was all cause mortality and hospitalization for cardiac failure at 12 months. 

Read also: Safety and Efficacy of Ticagrelor Monotherapy According to BMI.

The populations were similar: mean age was 79, 25% were diabetic, 82% hypertensive, 42% had CAD, 23% MI, 21% CABG, 11% stroke, 88% atrial fibrillation and NT-proBNP 2.022 pg/mL.

Patients presenting AKI were older (81 vs. 78 p=0.01), proportionally more were men (64.3% vs. 39,4% p=0.003), they had lower glomerular filtration 44.8 vs 51.4 (p=0.088) and higher EuroScore (7.98 vs. 4.9 p=0.003).

They had complete medical treatment. 

Read also: The New Sirolimus Eluting Balloons Are Also Effective.

Most procedures were done under general anesthesia. The most common device was MitraClip/TriClip, device failure was 5.6% and procedural success was 88.4%. Patients presenting AKI saw lower procedural success (79.3 vs. 90.6% p=0.03). 

Hospital mortality was higher in patients presenting AKI (9.5% vs. 0.9% p=0.006) as was bleeding and longer hospital stay. 

Primary end point at 12 months was higher among patients presenting AKI (66.2% vs 28.1%; P < 0.001).

AKI predictors were age, male sex, eGFR, left ventricular ejection fraction and procedural success. 

Conclusion

Acute kidney injury occurred in 15.7% of patients undergoing tricuspid transcatheter edge to edge repair despite no use of iodinated contrast agents. This situation was associated with worse evolution. 

These findings manifest the impact of acute kidney injury after transcatheter edge to edge repair of the tricuspid valve and should help identify patients at risk of acute kidney injury. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Acute Kidney Injury Following Tricuspid  Transcatheter Edge-to-Edge Repair. 

Reference: Tetsu Tanaka, et al. J Am Coll Cardiol Intv 2022;15:1936–1945.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Embolization of Left Atrial Appendage Closure Devices: Predictors, Prevention, and Management Strategies

Atrial fibrillation is associated with an increased risk of stroke and, in patients with contraindications to anticoagulation, percutaneous left atrial appendage closure represents an...

Coronary revascularization before TAVI: prior PCI or conservative management?

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

Percutaneous Mechanical Aspiration versus Surgical Treatment of Tricuspid Valve Endocarditis

Tricuspid valve infective endocarditis (TVIE) accounts for approximately 5% to 10% of all cases of infective endocarditis. Surgical treatment remains the standard therapy in...

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...